Advanced Biomed Inc. Common Stock (ADVB) vs NeuroOne Medical Technologies Corporation (NMTC)
A side-by-side comparison of Advanced Biomed Inc. Common Stock and NeuroOne Medical Technologies Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADVB
Advanced Biomed Inc. Common Stock
$6.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NMTC
NeuroOne Medical Technologies Corporation
$1.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ADVB vs NMTC
growth of $100 · dividends reinvested · last 2yADVB -91.3% (-70.5%/yr)NMTC -82.6% (-58.2%/yr)NMTC compounded faster over this window
ADVB NMTC
ADVB vs NMTC: by the numbers
- •NMTC is the larger company ($10M vs $9M market cap).
- •Both run net losses; ADVB's is the smaller (0.00% vs -71.51% net margin).
Metrics side by side
Valuation
| Metric | ADVB | NMTC |
|---|---|---|
| P/S ratio | N/A | 0.98 |
| P/B ratio | 0.96 | 2.61 |
Profitability
| Metric | ADVB | NMTC |
|---|---|---|
| Gross margin | 0.00% | 67.30% |
| Operating margin | 0.00% | -34.94% |
| Net margin | 0.00% | -71.51% |
| ROE | -7.36% | -189.76% |
| ROIC | -11.06% | -183.45% |
Growth (annualized)
| Metric | ADVB | NMTC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 37.21% |
| Total return CAGR (5Y) | N/A | -46.02% |
Go deeper
Dig into the metrics
Advanced Biomed Inc. Common Stock ROENeuroOne Medical Technologies ROEAdvanced Biomed Inc. Common Stock operating marginNeuroOne Medical Technologies operating marginAdvanced Biomed Inc. Common Stock revenue growthNeuroOne Medical Technologies revenue growthAdvanced Biomed Inc. Common Stock free cash flowNeuroOne Medical Technologies free cash flow
Advanced Biomed Inc. Common Stock & NeuroOne Medical Technologies appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.